Drug intelligence / Profile preview

Bu-Fei Jian-Pi

Development stage: Unknown
Administration: Oral

Overview

Bu-Fei Jian-Pi is a Traditional Chinese Medicine (TCM) granule used as part of a comprehensive therapy for patients with Chronic Obstructive Pulmonary Disease (COPD). It is typically administered alongside other TCM granules, such as Bu-Fei Yi-Shen and Yi-Qi Zi-Shen, tailored to specific TCM syndromes. Clinical studies indicate that this comprehensive TCM-based approach, including Bu-Fei Jian-Pi, can reduce the frequency of acute exacerbations, improve dyspnea, enhance exercise capacity, and alleviate symptoms, thereby improving the quality of life for patients with severe to very severe COPD.

Beyond the preview

Go deeper on Bu-Fei Jian-Pi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bu-Fei Jian-Pi.

Explore the full profile